Vera Therapeutics, Inc. (VERA)
USD 41.36
(-5.81%)
USD 41.36
(-5.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -92.18 Million | -67.59 Million | -23.7 Million | -34.8 Million | -10.28 Million |
| Net Income | -95.99 Million | -89.05 Million | -32.6 Million | -53.41 Million | -11.85 Million |
| Depreciation & Amortization | -1.86 Million | -846 Thousand | 176 Thousand | 251 Thousand | 509 Thousand |
| Deferred income taxes | 873 Thousand | - | -1.79 Million | 1.18 Million | 104 Thousand |
| Stock-based compensation | 11.49 Million | 8.88 Million | 3.01 Million | 331 Thousand | 263 Thousand |
| Change in working capital | -5.86 Million | 6.74 Million | 3.51 Million | 123 Thousand | 516 Thousand |
| Other non-cash items | -826 Thousand | 6.67 Million | 4 Million | 16.71 Million | 173 Thousand |
| Investing Cash Flow | -39.43 Million | -70.55 Million | -4.2 Million | -42 Thousand | -125 Thousand |
| Investments in PPE | -63 Thousand | -62 Thousand | - | -99 Thousand | -125 Thousand |
| Acquisitions | 39.36 Thousand | 70.49 Thousand | 796 Thousand | 57 Thousand | - |
| Investment purchases | -224.93 Million | -148.49 Million | - | - | - |
| Sales/Maturities of investments | 185.56 Million | 78 Million | - | - | - |
| Other Investing Activities | -39.36 Thousand | -70.49 Thousand | -5 Million | 57.00 | - |
| Financing Cash Flow | 133.54 Million | 101.93 Million | 53.88 Million | 85.29 Million | -137 Thousand |
| Debt repayment | -24.74 Million | -19.81 Million | -4.92 Million | -130 Thousand | -188 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 108.8 Million | 82.11 Million | 51.17 Million | 79.84 Million | 51 Thousand |
| Other Financing Activities | 49.48 Million | -6.09 Million | 7.62 Million | 5.57 Million | -137.00 |
| Accounts receivables | - | - | - | - | 159 Thousand |
| Accounts payables | -873 Thousand | 10.6 Million | 475 Thousand | 567 Thousand | -291 Thousand |
| Inventory | - | - | - | - | -159 Thousand |
| Other working capital | -4.99 Million | -3.85 Million | 3.03 Million | -444 Thousand | 807 Thousand |
| Cash at beginning of period | 43.45 Million | 79.96 Million | 53.99 Million | 3.55 Million | 14.1 Million |
| Cash at end of period | 45.68 Million | 43.75 Million | 79.96 Million | 53.99 Million | 3.55 Million |
| Capital Expenditure | -63 Thousand | -62 Thousand | - | -99 Thousand | -125 Thousand |
| Effect of forex changes on cash | 293 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 2.22 Million | -36.21 Million | 25.97 Million | 50.43 Million | -10.55 Million |
| Free Cash Flow | -92.24 Million | -67.65 Million | -23.7 Million | -34.9 Million | -10.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -33.7 Million | -28.38 Million | -95.99 Million | -25.65 Million | -20.1 Million | -20.16 Million |
| Depreciation & Amortization | 1.49 Million | -952 Thousand | -1.86 Million | -635 Thousand | -1.44 Million | -971 Thousand |
| Deferred income taxes | - | - | 873 Thousand | -3.13 Million | 15 Thousand | 29 Thousand |
| Stock-based compensation | 4.87 Million | 4.12 Million | 11.49 Million | 3.22 Million | 2.92 Million | 2.68 Million |
| Change in working capital | 6.14 Million | -8.61 Million | -5.86 Million | -2.07 Million | -4.91 Million | 86 Thousand |
| Other non-cash items | 3.32 Million | 8.12 Million | -826 Thousand | 3.13 Million | 549 Thousand | 564 Thousand |
| Investing Cash Flow | -22.67 Million | -219.28 Million | -39.43 Million | 18.55 Million | 16.22 Million | -86.44 Million |
| Investments in PPE | 24.78 Million | - | -63 Thousand | -63 Thousand | - | - |
| Acquisitions | - | - | 39.36 Thousand | -18.61 Thousand | - | - |
| Investment purchases | -81.08 Million | -254.96 Million | -224.93 Million | -53.2 Million | -28.67 Million | -108.84 Million |
| Sales/Maturities of investments | 58.5 Million | 35.68 Million | 185.56 Million | 71.81 Million | 44.9 Million | 22.4 Million |
| Other Investing Activities | -89 Thousand | -219.28 Thousand | -39.36 Thousand | 18.61 Thousand | 16.22 Thousand | -86.44 Thousand |
| Financing Cash Flow | 3.43 Million | 276.54 Million | 133.54 Million | 24.82 Million | 297 Thousand | 432 Thousand |
| Debt repayment | - | - | -24.74 Million | -24.74 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.43 Million | 276.54 Million | 108.8 Million | 87 Thousand | 297 Thousand | 432 Thousand |
| Other Financing Activities | 3.43 Million | -17.9 Million | 49.48 Million | 49.48 Million | 297.00 | 432.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -545 Thousand | -5.9 Million | -873 Thousand | -1.18 Million | -980 Thousand | 7.95 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.68 Million | -2.71 Million | -4.99 Million | -895 Thousand | -3.93 Million | -7.86 Million |
| Cash at beginning of period | 69.1 Million | 45.68 Million | 43.45 Million | 27.44 Million | 33.88 Million | 137.67 Million |
| Cash at end of period | 25.08 Million | 69.1 Million | 45.68 Million | 45.68 Million | 27.44 Million | 33.88 Million |
| Capital Expenditure | 24.78 Million | - | -63 Thousand | -63 Thousand | - | - |
| Effect of forex changes on cash | - | - | 293 Thousand | -115.84 Million | 9.37 Million | 106.47 Million |
| Net cash flow / Change in cash | -44.02 Million | 23.42 Million | 2.22 Million | 18.24 Million | -6.44 Million | -103.78 Million |
| Free Cash Flow | - | -33.83 Million | -92.24 Million | -25.2 Million | -22.97 Million | -17.77 Million |
2303
VEL
200570
2362
3526
BSSP